X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
riociguat (158) 158
pulmonary hypertension (85) 85
science & technology (85) 85
life sciences & biomedicine (84) 84
humans (72) 72
chronic thromboembolic pulmonary hypertension (64) 64
hypertension, pulmonary - drug therapy (50) 50
pulmonary arterial hypertension (49) 49
cardiovascular system & cardiology (38) 38
pyrazoles - therapeutic use (35) 35
pyrimidines - therapeutic use (35) 35
cardiac & cardiovascular systems (33) 33
respiratory system (31) 31
nitric oxide (26) 26
soluble guanylate cyclase (24) 24
female (23) 23
guanylate cyclase (22) 22
treatment outcome (22) 22
chronic disease (21) 21
male (21) 21
pyrazoles - pharmacology (21) 21
pyrimidines - pharmacology (21) 21
care and treatment (20) 20
soluble guanylyl cyclase (20) 20
hypertension, pulmonary - physiopathology (19) 19
pyrazoles - administration & dosage (19) 19
pyrimidines - administration & dosage (19) 19
animals (18) 18
guanylate cyclase - metabolism (17) 17
middle aged (17) 17
hypertension (16) 16
pharmacology & pharmacy (16) 16
aged (15) 15
drug therapy (15) 15
hypertension, pulmonary - etiology (14) 14
pyrazoles - adverse effects (14) 14
pyrimidines - adverse effects (14) 14
sildenafil (14) 14
soluble guanylate cyclase stimulator (13) 13
analysis (12) 12
heart failure (12) 12
macitentan (12) 12
nitric oxide - metabolism (12) 12
patients (11) 11
pulmonary endarterectomy (11) 11
thromboembolism (11) 11
adult (10) 10
antihypertensive agents - therapeutic use (10) 10
balloon pulmonary angioplasty (10) 10
clinical trials (10) 10
dose-response relationship, drug (10) 10
general & internal medicine (10) 10
quality of life (10) 10
research (10) 10
soluble guanylyl cyclase - metabolism (10) 10
cardiology (9) 9
double-blind method (9) 9
receptors, cytoplasmic and nuclear - metabolism (9) 9
bosentan (8) 8
endarterectomy (8) 8
medicine, general & internal (8) 8
peripheral vascular disease (8) 8
pulmonary embolism - complications (8) 8
pulmonary embolism - drug therapy (8) 8
pulmonary/respiratory (8) 8
receptors, cytoplasmic and nuclear - agonists (8) 8
review (8) 8
clinical trials as topic (7) 7
cteph (7) 7
cyclic gmp - metabolism (7) 7
diseases of the circulatory system (7) 7
hemodynamics (7) 7
hypertension, pulmonary - diagnosis (7) 7
hypertension, pulmonary - metabolism (7) 7
internal medicine (7) 7
medical research (7) 7
medicine (7) 7
medicine & public health (7) 7
pulmonary arteries (7) 7
respiratory agents (7) 7
treprostinil (7) 7
abridged index medicus (6) 6
cinaciguat (6) 6
drug administration schedule (6) 6
enzyme activators - administration & dosage (6) 6
health aspects (6) 6
heart (6) 6
hypertension, pulmonary - therapy (6) 6
medicine, experimental (6) 6
pulmonary embolism - physiopathology (6) 6
research article (6) 6
sgc stimulators (6) 6
signal transduction (6) 6
administration, oral (5) 5
antihypertensive agents - pharmacology (5) 5
cardiovascular (5) 5
clinical trial (5) 5
cyclic guanylic acid (5) 5
diseases of the respiratory system (5) 5
endothelin (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 07/2013, Volume 369, Issue 4, pp. 330 - 340
Journal Article
Portuguese Journal of Cardiology, ISSN 2174-2049, 2015, Volume 34, Issue 12, pp. 777.e1 - 777.e5
Abstract A 51-year-old woman presented with a one-year history of progressive dyspnea, WHO functional class III-IV and exercise-related syncope. Transthoracic... 
Cardiovascular | Chronic thromboembolic pulmonary hypertension | Treatment with riociguat | Tratamento com riociguat | Safety profile of riociguat | Hipertensão pulmonar tromboembólica crónica | Perfil de segurança do riociguat
Journal Article
Journal Article
International journal of cardiology, ISSN 0167-5273, 10/2020, Volume 317, pp. 188 - 192
RESPITE evaluated patients with pulmonary arterial hypertension and an inadequate response to phosphodiesterase type 5 inhibitors (PDE5i) who switched to... 
Pulmonary hemodynamics | Biomarkers | Pulmonary arterial hypertension | Switching to riociguat | Right heart function | Riociguat | Index Medicus
Journal Article
Pulmonary Circulation, ISSN 2045-8932, 6/2018, Volume 8, Issue 3, pp. 2045894018783996 - 2045894018783996
Riociguat is the treatment of choice for inoperable patients with chronic thromboembolic pulmonary hypertension (CTEPH). We addressed here whether additional... 
chronic thromboembolic pulmonary hypertension | balloon pulmonary angioplasty | targeted medication | riociguat | Thromboembolism | Angioplasty | Pulmonary hypertension
Journal Article
Journal Article